Liraglutide Downregulates Circulating Proglucagon-Derived Peptides, Improving Body Weight, Insulin Secretion, and Action
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Liraglutide Versus Placebo Treatment on Circulating Proglucagon-Derived Peptides That Mediate Improvements in Body Weight, Insulin Secretion and Action: A Randomized Controlled Trial
Diabetes Obes Metab 2020 Nov 02;[EPub Ahead of Print], SH Kim, F Abbasi, C Nachmanoff, K Stefanakis, A Kumar, B Kalra, G Savjani, CS MantzorosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.